Palmar plantar erythrodysesthesia historical perspective: Difference between revisions
(Created page with "{{Palmar plantar erythrodysesthesia}} {{CMG}} ==Overview== '''Palmar plantar erythrodysesthesia''' (PPE) is a swelling and numbness of the hands and feet that occurs with [[c...") |
No edit summary |
||
Line 5: | Line 5: | ||
'''Palmar plantar erythrodysesthesia''' (PPE) is a swelling and numbness of the hands and feet that occurs with [[chemotherapy]], usually with [[fluorouracil]], [[capecitabine]], [[cytarabine]], and [[doxorubicin]]. | '''Palmar plantar erythrodysesthesia''' (PPE) is a swelling and numbness of the hands and feet that occurs with [[chemotherapy]], usually with [[fluorouracil]], [[capecitabine]], [[cytarabine]], and [[doxorubicin]]. | ||
== | ==Historical perspective== | ||
First reported in association with chemotherapy by Zuehlke in 1974 (Zuehlke, 1974). | First reported in association with chemotherapy by Zuehlke in 1974 (Zuehlke, 1974). | ||
==References== | ==References== | ||
{{reflist|3}} | {{reflist|3}} |
Revision as of 16:46, 20 January 2012
Palmar plantar erythrodysesthesia Microchapters |
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
---|
Diagnosis |
Treatment |
Palmar plantar erythrodysesthesia historical perspective On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia historical perspective |
FDA on Palmar plantar erythrodysesthesia historical perspective |
CDC on Palmar plantar erythrodysesthesia historical perspective |
Palmar plantar erythrodysesthesia historical perspective in the news |
Blogs on Palmar plantar erythrodysesthesia historical perspective |
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Palmar plantar erythrodysesthesia (PPE) is a swelling and numbness of the hands and feet that occurs with chemotherapy, usually with fluorouracil, capecitabine, cytarabine, and doxorubicin.
Historical perspective
First reported in association with chemotherapy by Zuehlke in 1974 (Zuehlke, 1974).